Table 3.
Toxicity | Grade 1 (n) |
Grade 2 (n) |
Grade 3 (n) |
---|---|---|---|
AST | 5 | 1 | 1 |
ALT | 5 | 1 | |
Hyperbilirubinemia | 1 | ||
Alkaline phosphatase | 1 | 1 | |
Nausea | 1 | ||
Pain | |||
Headache, back, other | 3 | ||
Breast | 3 | ||
Limb | 3 | ||
Constipation | 1 | ||
Anorexia | 3 | 1 | |
Fatigue | 5 | 1 | |
Hemoglobin | 1 | ||
Vaginal dryness | 1 | ||
Diarrhea | 3 | ||
Hot flashes | 6 | ||
Limb edema | 6 |
NOTE: Grade 1 toxicities reported in >10% of patients (n = 28). No grade 4 or 5 events or treatment-related serious adverse events observed.